Sriharshita Musunuri is an MD-PhD Candidate at UCSF, where her work focuses on synthetic biology, programmable therapeutics, and the immune-microbiome interface. Previously, she worked on universal vaccine design for pandemic-potential pathogens such as Influenza and SARS-CoV-2 at the Stanford ChEM-H Institute, alongside computational methods to study protein dynamics at the Institute for Protein Design and D.E. Shaw Research. During this time, she also helped form the Stanford Existential Risks Initiative. She led their biosecurity efforts and presented at the 6th Global Health Security Agenda Ministerial Meeting on dual-use risks associated with countermeasure research. She is a fellow at the Council on Strategic Risks (CSR), and graduated with honors from Stanford University, where she studied biochemistry and computer science.